The case report: a tool for the toxicologist.
作者信息
Ruha Anne-Michelle
出版信息
J Med Toxicol. 2009 Mar;5(1):1-2. doi: 10.1007/BF03160972.
Abstract
摘要
相似文献
1
The case report: a tool for the toxicologist.
J Med Toxicol. 2009 Mar;5(1):1-2. doi: 10.1007/BF03160972.
2
The power of the case report.
J Med Toxicol. 2006 Dec;2(4):139-40. doi: 10.1007/BF03161180.
3
Case reports: unstylish but still useful sources of clinical information.
Reg Anesth Pain Med. 2009 May-Jun;34(3):187-8. doi: 10.1097/AAP.0b013e31819a2775.
4
Making Surveys Count: Enhancing the Rigor of Survey-Based Research in Medical Toxicology.
J Med Toxicol. 2016 Dec;12(4):329-331. doi: 10.1007/s13181-016-0565-5. Epub 2016 Jun 24.
5
Case reports in medicine.
Ear Nose Throat J. 2013 Aug;92(8):324-6. doi: 10.1177/014556131309200802.
6
Writing a case report: polishing a gem?
Int Angiol. 2008 Aug;27(4):344-9.
7
Writing a case report.
Radiol Technol. 2008 Sep;80(1):79-82.
8
Mind your language: conveying the results of clinical trials of cardiovascular therapies.
Cardiovasc Ther. 2013 Feb;31(1):1. doi: 10.1111/j.1755-5922.2012.00316.x.
9
Comparative effectiveness research: challenges for medical journals.
Croat Med J. 2010 Jun;51(3):191-4. doi: 10.3325/cmj.2010.51.191.
10
Comparative effectiveness research: Challenges for medical journals.
Cochrane Database Syst Rev. 2010 Apr 27;2011(4):ED000003. doi: 10.1002/14651858.ED000003.
引用本文的文献
1
Medical Toxicology vs. Emergency Medicine and Internal Medicine - Are We Really Full of Case Reports?
J Med Toxicol. 2024 Oct;20(4):401-406. doi: 10.1007/s13181-024-01031-y. Epub 2024 Sep 20.
2
Response to Comment on "Cardiovascular and Adverse Effects of Glucagon for the Management of Suspected Beta Blocker Toxicity: a Case Series".
J Med Toxicol. 2023 Apr;19(2):235-236. doi: 10.1007/s13181-023-00937-3. Epub 2023 Mar 3.
3
Comment on "Cardiovascular and Adverse Effects of Glucagon for the Management of Suspected Beta Blocker Toxicity: a Case Series".
J Med Toxicol. 2023 Apr;19(2):233-234. doi: 10.1007/s13181-023-00935-5. Epub 2023 Mar 3.
4
Reviewing the Record: Medical Record Reviews for Medical Toxicology Research.
J Med Toxicol. 2018 Sep;14(3):179-181. doi: 10.1007/s13181-018-0678-0. Epub 2018 Jul 31.
5
When Your N >1: Drawing Meaningful Conclusions from Registry Studies.
J Med Toxicol. 2016 Sep;12(3):219-20. doi: 10.1007/s13181-016-0581-5. Epub 2016 Aug 10.
6
Enriching the Toxicology Experience through Twitter.
J Med Toxicol. 2015 Dec;11(4):385-7. doi: 10.1007/s13181-015-0508-6.
7
Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology.
Semin Dial. 2014 Jul-Aug;27(4):407-14. doi: 10.1111/sdi.12251. Epub 2014 May 29.
8
Fostering an environment for research: a fellow's perspective.
J Med Toxicol. 2011 Jun;7(2):103-4. doi: 10.1007/s13181-011-0146-6.
本文引用的文献
1
The power of the case report.
J Med Toxicol. 2006 Dec;2(4):139-40. doi: 10.1007/BF03161180.
2
WJES and case reports/case series.
World J Emerg Surg. 2007 May 8;2:11. doi: 10.1186/1749-7922-2-11.
3
Guidelines for submitting adverse event reports for publication.
Drug Saf. 2007;30(5):367-73. doi: 10.2165/00002018-200730050-00001.
4
Proposal for a new tool to evaluate drug interaction cases.
Ann Pharmacother. 2007 Apr;41(4):674-80. doi: 10.1345/aph.1H423. Epub 2007 Mar 27.
5
Case reports and case series from Lancet had significant impact on medical literature.
J Clin Epidemiol. 2005 Dec;58(12):1227-32. doi: 10.1016/j.jclinepi.2005.04.003. Epub 2005 Sep 12.
6
Ethylene glycol exposure: an evidence-based consensus guideline for out-of-hospital management.
Clin Toxicol (Phila). 2005;43(5):327-45. doi: 10.1080/07313820500184971.
7
beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management.
Clin Toxicol (Phila). 2005;43(3):131-46.
8
Instructions to authors for case reporting are limited: a review of a core journal list.
BMC Med Educ. 2004 Mar 25;4:4. doi: 10.1186/1472-6920-4-4.
9
THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION?
Proc R Soc Med. 1965 May;58(5):295-300. doi: 10.1177/003591576505800503.
10
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther. 1981 Aug;30(2):239-45. doi: 10.1038/clpt.1981.154.
Zotero 插件